Friday, December 4th | 18 Kislev 5781

Subscribe
November 16, 2020 12:38 pm

Moderna Covid-19 Vaccine Hailed as Benefit of US-Israel Cooperation

avatar by Algemeiner Staff

Vials with stickers reading ‘COVID-19 / Coronavirus vaccine / Injection only’ and a syringe are seen in front of a displayed Moderna logo, in this illustration taken on Oct. 31, 2020. Photo: Reuters / Dado Ruvic / Illustration / File.

America’s envoy to the Jewish state on Monday hailed US-Israel cooperation after Moderna announced that its experimental Covid-19 vaccine was 94.5% effective in preventing the disease.

Noting that Moderna’s chief medical officer, Tal Zaks, was an Israeli who studied at Ben-Gurion University of the Negev, Ambassador David Friedman tweeted, “Another great example of Israelis and Americans working together to make the world a better place!”

Zaks told BBC News on Monday, “The overall effectiveness has been remarkable… it’s a great day.”

In early June, as reported by The Algemeiner, Zaks credited “the first-rate education” he got at Ben-Gurion University, but noted that the story of how Israel put him on his present course “actually starts from the times I was a medic in the IDF.”

At the time, Zaks predicted Massachusetts-based Moderna would be able to produce “a billion doses” of a Covid-19 vaccine in 2021.

Later in June, Israel signed a deal with Moderna for the future purchase of its vaccine.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.